Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin nasal spray for hemostasis in rhinoplasty
IRCT20210424051060N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of desmopressin in rhinoplasty (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Bleeding. Started May 2021; status: completed.
02
Drugs
desmopressin
03
Conditions
rhinoplasty
Beyond the preview
Go deeper on IRCT20210424051060N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210424051060N1.